Mutant ryanodine receptors in catecholaminergic polymorphic ventricular tachycardia generate delayed afterdepolarizations due to increased propensity to Ca2+ waves

被引:61
|
作者
Paavola, Jere
Viitasalo, Matti
Laitinen-Forsblom, Paivi J.
Pasternack, Michael
Swan, Heikki
Tikkanen, Ilkka
Toivonen, Lauri
Kontula, Kimmo
Laine, Mika [1 ]
机构
[1] Inst Med Res, Minerva Fdn, FIN-00290 Helsinki, Finland
[2] Univ Helsinki, Cent Hosp, Dept Cardiol, FIN-00290 Helsinki, Finland
[3] Univ Helsinki, Dept Med, FIN-00290 Helsinki, Finland
关键词
arrhythmia; calcium; mutation; cAMP; HEK293; cells; heart failure; sudden death;
D O I
10.1093/eurheartj/ehl543
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aims Mutations in cardiac ryanodine receptors (RyR2s) are linked to catechotaminergic polymorphic ventricular tachycardia (CPVT), characterized by risk of polymorphic ventricular tachyarrhythmias and sudden death during exercise. Arrhythmias are caused by gain-of-function defects in RyR2, but cellular arrhythmogenesis remains elusive. Methods and results We recorded endocardial monophasic action potentials (MAPs) at right ventricular septum in 15 CPVT patients with a RyR2 mutation (P2328S, Q4201R, and V4653F) and in 12 control subjects both at baseline and during epinephrine infusion (0.05 mu g/kg/min). At baseline 3 and during epinephrine infusion, four CPVT patients, but none of the control subjects, showed delayed afterdepolarizations (DADs) occasionally coinciding with ventricular premature complexes. In order to study the underlying mechanisms, we expressed two types of mutant RyR2 (P2328S and V4653F) causing CPVT as well as wild-type RyR2 in HEK 293 cells. Confocal microscopy of Fluo-3 loaded cells transfected with any of the three RyR2s showed no spontaneous subcellular Ca2+ release events at baseline. Membrane permeable cAMP analogue (Dioctanoyl-cAMP) triggered subcellular Ca2+ release events as Ca2+ sparks and waves. Celts expressing mutant RyR2s showed spontaneous Ca2+ release events at tower concentrations of cAMP than cells transfected with wild-type RyR2. Conclusion CPVT patients show DAN coinciding with premature action potentials in MAP recordings. Expression studies suggest that DAN are caused by increased propensity of abnormal RyR2s to generate spontaneous Ca2+ waves in response to cAMP stimulation. Increased sensitivity of mutant RyR2s to cAMP may explain the occurrence of arrhythmias during exercise or emotional stress in CPVT.
引用
收藏
页码:1135 / 1142
页数:8
相关论文
共 50 条
  • [21] Gene Therapy for Catecholaminergic Polymorphic Ventricular Tachycardia by Inhibition of Ca2+/Calmodulin-Dependent Kinase II
    Bezzerides, Vassilios J.
    Caballero, Ana
    Wang, Suya
    Ai, Yulan
    Hylind, Robyn J.
    Lu, Fujian
    Heims-Waldron, Danielle A.
    Chambers, Kristina D.
    Zhang, Donghui
    Abrams, Dominic J.
    Pu, William T.
    CIRCULATION, 2019, 140 (05) : 405 - 419
  • [22] Enhanced sensitivity of the cardiac ryanodine receptor to activation by luminal Ca2+ as a primary cause of catecholaminergic polymorphic ventricular tachyeardia
    Uchinoumi, Hitoshi
    Yano, Masafumi
    Ohno, Makoto
    Xu, Xiaojuan
    Tateishi, Hiroki
    Kobayashi, Shigeki
    Yamamoto, Takeshi
    Ikeda, Yasuhiro
    Matsuzaki, Masunori
    CIRCULATION, 2007, 116 (16) : 153 - 153
  • [23] Dynamics of Ca2+ transients in initiation of early afterdepolarizations and triggered ventricular tachycardia: Effects of ryanodine and verapamil in isolated rabbit hearts
    Wu, Y
    Hou, C
    Lu, T
    Anderson, ME
    Sung, RJ
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1997, 29 (02) : 9085 - 9085
  • [24] Mutations in the cardiac ryanodine receptor gene (hRyR2) underlie catecholaminergic polymorphic ventricular tachycardia
    Priori, SG
    Napolitano, C
    Tiso, N
    Memmi, M
    Vignati, G
    Bloise, R
    Sorrentino, V
    Danieli, GA
    CIRCULATION, 2001, 103 (02) : 196 - 200
  • [25] Resolving a Controversy: Inhibition of Cardiac Ryanodine Receptors is the Principal Mechanism of Antiarrhythmic Action of Flecainide in Catecholaminergic Polymorphic Ventricular Tachycardia
    Kryshtal, Dmytro O.
    Blackwell, Daniel J.
    Egly, Christian L.
    Smith, Abigail N.
    Batiste, Suzanne M.
    Johnston, Jeffrey N.
    Laver, Derek R.
    Knollmann, Bjorn C.
    CIRCULATION, 2020, 142
  • [26] Ryanodine receptor 2 mutation: Not only catecholaminergic polymorphic ventricular tachycardia but also epileptiform discharges in electroencephalogram
    She, Yingfang
    Li, Yide
    Yu, Hang
    Zhou, Liemin
    NEUROLOGY ASIA, 2020, 25 (03) : 387 - 394
  • [27] Calcium Leak Through Ryanodine Receptors Leads to Atrial Fibrillation in 3 Mouse Models of Catecholaminergic Polymorphic Ventricular Tachycardia
    Shan, Jian
    Xie, Wenjun
    Betzenhauser, Matthew
    Reiken, Steven
    Chen, Bi-Xing
    Wronska, Anetta
    Marks, Andrew R.
    CIRCULATION RESEARCH, 2012, 111 (06) : 708 - +
  • [28] Dantrolene Inhibits Spontaneous Ca2+ Release as a Substrate for Catecholaminergic Polymorphic Ventricular Tachycardia (PSVT) by Correcting Defective Inter-Domain Interaction Within the Ryanodine Receptor
    Kobayashi, Shigeki
    Yano, Masafumi
    Suetomi, Takeshi
    Ono, Makoto
    Xu, Xiaojuan
    Uchinoumi, Hitoshi
    Tateishi, Hiroki
    Okuda, Shinichi
    Yamamoto, Takeshi
    Matsuzaki, Masunori
    CIRCULATION, 2008, 118 (18) : S921 - S921
  • [29] Late Na+ Current Contributes to Arrhythmogenic Diastolic Ca2+ release in catecholaminergic polymorphic ventricular tachycardia (CPVT)
    Radwanski, Przemyslaw
    Ho, Hsiang-Ting
    Knollmann, Bjorn
    Belevych, Andriy
    Gyorke, Sandor
    FASEB JOURNAL, 2016, 30
  • [30] Comparison of Ca2+ release properties of RyR2 mutations causing catecholaminergic polymorphic ventricular tachycardia versus idiopathic ventricular fibrillation
    Kurebayashi, Nagomi
    Murayama, Takashi
    Ohta, Ryosaku
    Yamashita, Fumiyoshi
    Suzuki, Junji
    Kanemaru, Kazunori
    Iino, Masamitsu
    Sakurai, Takashi
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2016, 130 (03) : S104 - S104